Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.Unknown journal · 2026-03-23An open-label pilot study of psilocybin-assisted therapy for binge eating disorderJournal of Eating Disorders · 2026-01-02Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic reviewBJPsych Open · 2025-10-31Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility studyAddiction · 2025-09-19Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortexTranslational Psychiatry · 2025-03-24Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and TranylcypromineJournal of Psychoactive Drugs · 2024-06-20Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Unknown journal · 2024-03-31Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainMolecular Psychiatry · 2024-02-19Psilocybin induces dose-dependent changes in functional network organization in rat cortexbioRxiv · 2024-02-11Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy PersistsAJOB Neuroscience · 2024-02-04Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic painCurrent Biology · 2023-11-30Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic painbioRxiv · 2023-08-27Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.International Journal of Molecular Sciences · 2022-11-15A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.Unknown journal · 2022-09-11The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Unknown journal · 2022-04-25Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience Applied · 2022-03-06P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-11-30Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.Unknown journal · 2021-11-16Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Unknown journal · 2021-05-17Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.Frontiers in psychiatry · 2020-12-31The emerging role of psilocybin and MDMA in the treatment of mental illness.Unknown journal · 2020-09-29